Cai Y, Miller CL, […] Yan C. Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells. Arteriosclerosis, Thrombosis and Vascular Biology. 2010 Dec 9;31(3): 616-23. Miller CL, Yan C. Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications. Journal of Cardiovascular Translational Research. 2010 Oct;3(5): 507-15. Miller CL,

Miller CL, Oikawa M, Cai Y, […] Yan C. Cyclic nucleotide phosphodiesterase 1: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart. Basic Research in Cardiology. 2011 Nov;106(6): 1023-39.

Miller CL, Anderson DR, Kundu RK, […] Quertermous T. Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus. PLoS Genetics 2013 Jul;9(7):e1003652. Leeper NJ, Raiesdana A, Kojima Y, […] Miller CL, […] Quertermous T. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and

Miller CL, Haas U, Diaz R, […] Quertermous T, Sczakiel G†. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genetics . 2014 Mar 27; 10(3):e1004263. Miller CL, Assimes TL, Montgomery SB, Quertermous T. Dissecting the causal genetic mechanisms of coronary heart disease. Current Atherosclerosis Reports. 2014 May;16(5):406. Kojima

Miller CL*, Pjanic M*, Quertermous T. From locus association to mechanism of gene causality: the devil is in the details. Arteriosclerosis, Thrombosis and Vascular Biology. 2015 Oct;35(10):2079-80. Nürnberg ST*, Cheng K*, […] Miller CL, […] Quertermous T. TCF21 regulates smooth muscle cell precursor cells that contribute to the fibrous cap. PLoS Genetics. 2015 May 28;11(5):e1005155.